+ Watch SSRX
on My Watchlist
The Company is engaged in the research, development, manufacture and distribution of pharmaceutical products in the China.
New Chief Science Officer, Dr Yingfei Wei came from a company, Elixirin, ( http://www.elixirin.com/ ) that sold an anti aging pill based upon green tea leaves, just when green tea leaves were steaming (haha). Now she heads a bio-pharm that some describe as the next Amgen? Pitches describe no R&D as a good thing because pirating drugs is easy and cheap. So giving them our investment dollars is smart because they steal? All the cash on the books came from a share issuing without which this company has no money. I guess the money was needed for the R&D they do not do? The interest from the stock offering doubled their earnings. Not sales. Also there is a very nice picture of a building on their website. They pitch EPIAO as a help with anemia in cancer patients but apparently it has other uses, more fitting to Ms Wei's experience selling anti-aging creams. http://www.globalsteroids.com/y1Epiao-.html Their other "flagship product" TPIAO does not exist on the web except in stock analysis or press releases. Their website also has a message board, one would assume would likely be used for discussions of the drugs side effects, benefits, that sort of thing. You would think at least one person would have a complaint. Pay special attention to the "managers answers" they will tell you what this company does besides build bodys. And keep reading until you come to some english questions. It is amazing what people will talk about on this Biopharm website.I suppose it is possible that this mail order steroid will become FDA approved for use with cancer treatments, and this company will go on to be the "next amgen", but I think your money would be safer in the "real amgen".
What's the deal with the tea leaves? Given that Traditional Chinese Medicine is based on plants are we surprised? TPIAO is the English name for the Chinese product - given that it's sold in China would we expect to see the English name thrown around the web - or would we expect the Chinese name? Good point about earnings being attributed to interest - so if there is earnings growth this year, assuming interests rates don't increase, then it might be masked by the flat growth from the cash earnings.Thank you very enlightening.rich(CAPS pick but no position)
Interesting post. I understand the satirical skepticism which is fundamentally valid. However, until I give this company a technical look I will not be able to succeed to your advise. So, why would I even reply. Good question. I hope to get back to it soon.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions